Fortis Healthcare arm SRL Diagnostics may tap Kotak, I-Sec and Morgan Stanley for IPO launch
News2023-04-13
2 Views
The promoter group holds 57.68 percent stake while the bloc of private equity investors holds 31.52 percent in SRL Diagnostics. The investors include the likes of NY Jacob Ballas and the World Bank#39;s development finance arm IFC
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
